Cenfeng Chu

648 total citations
9 papers, 520 citations indexed

About

Cenfeng Chu is a scholar working on Molecular Biology, Sensory Systems and Cognitive Neuroscience. According to data from OpenAlex, Cenfeng Chu has authored 9 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Sensory Systems and 2 papers in Cognitive Neuroscience. Recurrent topics in Cenfeng Chu's work include Hearing, Cochlea, Tinnitus, Genetics (6 papers), RNA regulation and disease (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). Cenfeng Chu is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (6 papers), RNA regulation and disease (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). Cenfeng Chu collaborates with scholars based in China, India and United States. Cenfeng Chu's co-authors include Jieyu Qi, Renjie Chai, Guisheng Zhong, Shuijin He, Yan Liu, Chao Zhong, Weijie Zhu, Fangzhi Tan, Xin Chen and Yunbo Qiao and has published in prestigious journals such as Nature Communications, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Cenfeng Chu

9 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cenfeng Chu China 7 350 259 90 83 55 9 520
Batiste Boëda France 10 291 0.8× 471 1.8× 73 0.8× 53 0.6× 75 1.4× 17 889
Yazhi Xing China 14 300 0.9× 187 0.7× 116 1.3× 155 1.9× 64 1.2× 34 591
Buwei Shao China 8 248 0.7× 169 0.7× 78 0.9× 58 0.7× 44 0.8× 12 373
Patrick J. Atkinson United States 12 459 1.3× 196 0.8× 96 1.1× 208 2.5× 155 2.8× 19 747
Fuping Qian China 10 196 0.6× 176 0.7× 62 0.7× 34 0.4× 86 1.6× 16 437
Luo Guo China 18 521 1.5× 473 1.8× 128 1.4× 118 1.4× 63 1.1× 44 940
Diane M. Prieskorn United States 18 639 1.8× 210 0.8× 214 2.4× 293 3.5× 110 2.0× 34 1.0k
Litao Tao United States 10 238 0.7× 144 0.6× 27 0.3× 71 0.9× 42 0.8× 19 381
Shigetoshi Fujita Japan 14 255 0.7× 217 0.8× 132 1.5× 40 0.5× 16 0.3× 27 557
Heather Jensen‐Smith United States 11 133 0.4× 214 0.8× 30 0.3× 36 0.4× 59 1.1× 21 436

Countries citing papers authored by Cenfeng Chu

Since Specialization
Citations

This map shows the geographic impact of Cenfeng Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cenfeng Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cenfeng Chu more than expected).

Fields of papers citing papers by Cenfeng Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cenfeng Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cenfeng Chu. The network helps show where Cenfeng Chu may publish in the future.

Co-authorship network of co-authors of Cenfeng Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Cenfeng Chu. A scholar is included among the top collaborators of Cenfeng Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cenfeng Chu. Cenfeng Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhao, Simeng, Cenfeng Chu, S. Dai, et al.. (2025). Deciphering enhancers of hearing loss genes for efficient and targeted gene therapy of hereditary deafness. Neuron. 113(10). 1579–1596.e5. 1 indexed citations
2.
Tao, Yong, Yang Liu, Cenfeng Chu, et al.. (2022). AAV-ie-K558R mediated cochlear gene therapy and hair cell regeneration. Signal Transduction and Targeted Therapy. 7(1). 109–109. 52 indexed citations
3.
Qi, Jieyu, Liyan Zhang, Fangzhi Tan, et al.. (2020). Espin distribution as revealed by super-resolution microscopy of stereocilia.. PubMed. 12(1). 130–141. 49 indexed citations
4.
Chu, Cenfeng, Guisheng Zhong, & Hui Li. (2020). Structure and function of subcortical periodic cytoskeleton throughout the nervous system. SHILAP Revista de lepidopterología. 1(1). e9–e9. 1 indexed citations
5.
Liu, Yan, Jieyu Qi, Xin Chen, et al.. (2019). Critical role of spectrin in hearing development and deafness. Science Advances. 5(4). eaav7803–eaav7803. 117 indexed citations
6.
Qi, Jieyu, Yan Liu, Cenfeng Chu, et al.. (2019). A cytoskeleton structure revealed by super-resolution fluorescence imaging in inner ear hair cells. Cell Discovery. 5(1). 12–12. 64 indexed citations
7.
Tan, Fangzhi, Cenfeng Chu, Jieyu Qi, et al.. (2019). AAV-ie enables safe and efficient gene transfer to inner ear cells. Nature Communications. 10(1). 3733–3733. 173 indexed citations
8.
Zhao, Han, Liang Chen, Guisheng Zhong, et al.. (2019). Titanium Dioxide Nanoparticles Induce Mitochondrial Dynamic Imbalance and Damage in HT22 Cells. Journal of Nanomaterials. 2019. 1–16. 20 indexed citations
9.
An, Bolin, Xinyu Wang, Mengkui Cui, et al.. (2017). Diverse Supramolecular Nanofiber Networks Assembled by Functional Low-Complexity Domains. ACS Nano. 11(7). 6985–6995. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026